McKenna Mark C. 4
4 · NewAmsterdam Pharma Co N.V. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
McKenna Mark C.
Director
Transactions
- Award
Ordinary Shares
2025-01-07+6,960→ 6,960 total - Award
Option (right to buy)
2025-01-06+32,500→ 32,500 totalExercise: $25.85Exp: 2035-01-06→ Ordinary Shares (32,500 underlying)
Footnotes (3)
- [F1]Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
- [F2]Each RSU was granted on January 7, 2025 for no consideration.
- [F3]1/3 of the shares underlying the option will vest on January 6, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date.